“I need to be blunt: The world is on the brink of a catastrophic moral failure — and the price of this failure will be paid with lives and livelihoods in the world’s poorest countries,” he said, noting that although 39 million doses have been administered in more than 40 higher-income countries, one poor country has given only 25 doses.
Although Tedros hailed the vaccine rollout as a great scientific achievement, he noted that there are lessons to be learned from past global pandemics when vaccines took a long time to reach developing countries. The current crisis was a chance to “rewrite history,” by ensuring that vaccines are distributed fairly between countries and to those who need them the most.
WHO has partnered with several vaccine makers to provide 2 billion doses to a consortium of low-income countries in an initiative dubbed Covax, but Tedros said there are concerns that the vaccines won’t be delivered.
“Even as they speak the language of equitable access, some countries and companies continue to prioritize bilateral deals, going around Covax, driving up prices and attempting to jump to the front of the queue,” he said.
He called on wealthier countries to hold off on vaccinating their young and healthier adults so that older people and front-line health-care workers in developing countries could receive their doses.
His warning came as wealthier nations such as Britain scramble to vaccinate the vulnerable amid a fresh outbreak of the virus that experts say was triggered by a new and highly contagious variant that his since been identified in many other countries.
The British government has vowed to vaccinate its four priority groups — which include National Health Service workers and care home residents — by Feb. 15.
England’s Department of Health and Social Care said Sunday that an estimated 45 percent of people older than 80 have now been vaccinated and that more than 1 million people within the age group had been invited to schedule their vaccine appointments.
In Europe, several countries, including Finland and Sweden, have expressed concern and anger that shipments of the Pfizer vaccine have been delayed, saying the setback — which the U.S. firm called a temporary delay — is “unacceptable.”
European Commission President Ursula von der Leyen said last week that Pfizer had agreed to supply the E.U. with 600 million doses this year.
Those in Africa face a much longer wait for help, with the Africa Centers for Disease Control and Prevention estimating that a distribution program may not begin until April.
Ahmed Ogwell Ouma, deputy director of the Africa CDC, said last month that those in African nations are “often holding the short end of the stick.”
India, which has the second-highest coronavirus caseload in the world, is also beginning mass-vaccination efforts and hopes to immunize about 300 million people by summer — despite concerns that one of the vaccines may not work.